0001746139-24-000003.txt : 20241231
0001746139-24-000003.hdr.sgml : 20241231
20241231095027
ACCESSION NUMBER: 0001746139-24-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20241231
DATE AS OF CHANGE: 20241231
EFFECTIVENESS DATE: 20241231
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Auron Therapeutics, Inc.
CENTRAL INDEX KEY: 0001746139
ORGANIZATION NAME:
IRS NUMBER: 823865673
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-533785
FILM NUMBER: 241591403
BUSINESS ADDRESS:
STREET 1: 55 CHAPEL STREET
STREET 2: SUITE 102
CITY: NEWTON
STATE: MA
ZIP: 02458
BUSINESS PHONE: 310-922-5881
MAIL ADDRESS:
STREET 1: 55 CHAPEL STREET
STREET 2: SUITE 102
CITY: NEWTON
STATE: MA
ZIP: 02458
D
1
primary_doc.xml
X0708
D
LIVE
0001746139
Auron Therapeutics, Inc.
55 Chapel Street
Suite 102
Newton
MA
MASSACHUSETTS
02458
310-922-5881
DELAWARE
None
None
Corporation
true
Katharine
Yen
55 Chapel Street
Suite 102
Newton
MA
MASSACHUSETTS
02458
Executive Officer
Director
Alexandra
Cantley
55 Chapel Street
Suite 102
Newton
MA
MASSACHUSETTS
02458
Director
Briggs
Duncan
Morrison
55 Chapel Street
Suite 102
Newton
MA
MASSACHUSETTS
02458
Director
Anna
French
55 Chapel Street
Suite 102
Newton
MA
MASSACHUSETTS
02458
Director
Alon
Lazarus
55 Chapel Street
Suite 102
Newton
MA
MASSACHUSETTS
02458
Director
Serge
Messerlian
55 Chapel Street
Suite 102
Newton
MA
MASSACHUSETTS
02458
Director
Victoria
Richon
55 Chapel Street
Suite 102
Newton
MA
MASSACHUSETTS
02458
Director
Biotechnology
Decline to Disclose
- 06b
false
2024-12-18
true
true
false
0
41789180
13394590
28394590
false
15
0
0
0
false
Auron Therapeutics, Inc.
/s/ Katharine Yen
Katharine Yen
Chief Executive Officer
2024-12-31